Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded cytochrome b pseudogene 4 (MTCYBP4) is annotated as a pseudogene related to the mitochondrial cytochrome b gene (MT-CYB), which is a functional component of mitochondrial complex III involved in oxidative phosphorylation and ATP production. Pseudogenes such as MTCYBP4 are sequences similar to known genes but are generally considered nonfunctional due to mutations, truncations, or lack of expression. There is no evidence that MTCYBP4 encodes a functional protein or plays a role in human health or disease, nor is it considered a therapeutic target. Most research and clinical associations pertain to the canonical MT-CYB gene, not its pseudogenes[1][2][3][4]. If you intended to inquire about the functional mitochondrial gene, use "Mitochondrially encoded cytochrome b (MT-CYB)", which encodes a key subunit of complex III (cytochrome bc1 complex) in the mitochondrial electron transport chain; that gene plays a fundamental role in cellular energy generation and is associated with various mitochondrial diseases and some cancers[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded cytochrome b pseudogene 4 (MTCYBP4).